Bibliography
- BELL C, ABRAMS J, NUTT D: Tryptophan depletion and its implications for psychiatry. Br. J. Psychiatry (2001) 178:399-405.
- RIEDEL WJ: Cognitive changes after acute tryptophan depletion: what do they tell us? Psychol. Med. (2004) 34:3-8.
- TALBOT PS, COOPER SC: Anterior cingulate and subgenual prefrontal blood flow changes following tryptophan depletion in healthy males. Neuropsychopharmacology (2006) 31(8):1757-1767.
- CAHIR M: Effect of acute and chronic tryptophan depletion on serotonergic metabolism and receptors in rat brain. J. Psychopharmacology (2006) 20(Suppl.):A2.
- STAHL SM: Mechanism of action of serotonin selective reuptake inhibitors. J. Affect. Disord. (1998) 51:215-235.
- TALBOT PS: Functional neuroimaging of rapid tryptophan depletion. J. Psychopharmacol. (2006) 20(Suppl.):A2.
- LIEBERMAN JA, STROUP TS, MCEVOY JP et al.: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. (2005) 353(12):1209-1223.
- ELLENBROEK BA: Gene-environment interactions in animal models for schizophrenia. J. Psychopharmacol. (2006) 20(Suppl.):A3.
- REYNOLDS GP: Receptor mechanisms in the treatment of schizophrenia. J. Psychopharmacol. (2004) 18:340-345.
- GREEN MF, NUECHTERLEIN KH, GOLD JM et al.: Approaching a consensus clinical battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria. Biol. Psychiatry (2004) 56:301-307.
- HAHN C-Y, WANG H-Y, CHO D-S et al.: Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat. Med. (2006) 12:824-828.
- COOLEN MW, VAN LOO K, VAN BAKEL N: Gene dosage effect on γ-secretase component Aph-1B in a rat model for neurodevelopmental disorders. Neuron (2005) 45:497-503.
- JONES DNC: Effects of isolation rearing and subchronic PCP in rats: behavioural, pharmacological, neurochemical and transcriptomic investigation. J. Psychopharmacology (2006) 20(Suppl.):A3.
- HAGAN JJ, JONES DNC: Predicting drug efficacy for cognitive deficits in schizophrenia. Schizophr. Bull. (2005) 31:830-853.
- REYNOLDS LM, COCHRAN SM, MORRIS BJ, PRATT AP, REYNOLDS GP: Chronic phencyclidine administration induces schizophrenia like changes in N-acetylaspartate and N-acetylaspartlyglutamate in rat brain. Schizophr. Res. (2005) 73:147-152.
- COCHRAN SM, KENNEDY M, MCKERCHAR CE, STEWARD LJ, PRATT JA, MORRIS BJ: Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs. Neuropsychopharmacology (2003) 28:265-275.
- PLOTSKY PM: Tuning developmental outcomes via environmental cues: Reintegrating biological and psychosocial precepts. J. Psychopharmacology (2006) 20(Suppl.):A73.
- HEIM C, PLOTSKY PM, NEMEROFF CB: Importance of studying the contributions of early adversive experience to neurobiological findings in depression. Neuropsychopharmacology (2004) 29:641-648.
- DETTLING AC, FELDON J, PRYCE CR: Repeated parental deprivation in the infant common marmoset and analysis of its effects on early development. Biol. Psychiatry (2002) 56:72-79.
- DETTLING AC, FELDON J, PRYCE CR: Early deprivation and behavioural and physiological responses to social separation/novelty in the marmoset. Pharmacol. Biochem. Behav. (2002) 73:259-269.
- PEI Q, LAW AJ, FELDON J, PRYCE CR, HARRISON PJ: Alterations in gene expression of synaptic markers in the brain of marmosets exposed to early life stress. J. Psychopharmacol (2006) 20(Suppl.):A64.